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1. Introduction 
A field study by World Health Organization (WHO), World Bank and Harvard University 
in 1990 found a changing pattern of diseases caused by unhealthy lifestyle changes that may 
eventually lead to metabolic syndrome, type 2 diabetes mellitus, coronary arterial diseases, 
depression, and traffic accidents (Kinsella and Phillips, 2005). The study also predicted that 
cerebrovascular diseases would become the most prevalent disease, whereas human HIV 
infection would sharply increase in the year 2020 (Kinsella and Phillips, 2005). The lifestyle-
related and degenerative diseases are significant problems in the old aged population 
group. 
The number of elderly population has increased worldwide, and recently it has been 
increasing sharply in the developing countries. The projection of the number of elderly 
population in Indonesia by the year 2010 is 23,992. The Indonesian Central Bureau for 
Statistics (Badan Pusat Statistik) has reported that Indonesia is the world’s fourth in the 
number of elderly population after China, India, and USA (Komala et al., 2005). US Bureau 
of Census predicted that from 1990 to 2020, the Indonesian elderly population would 
increase to 41.4%. The predicted increased number of elderly was ascribed to the success of 
health promotion and improvement of social and economic status (Kinsella and Taeuber, 
1993).  
Metabolic disorders including type 2 diabetes mellitus (T2DM) and cardiovascular diseases  
are closely related with the aging process. Central obesity and insulin resistance as the initial 
preconditions and its consequences related to  metabolic diseases and cardiovascular 
diseases are frequently found among the elderly. Decline in lean body mass and increase in 
body fat, particularly visceral adiposity that often accompanies aging, may contribute to the 
development of insulin resistance. As for the mechanism of T2DM, it is known that aging 
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induces a decrease of insulin sensitivity and alteration or insufficient compensation of beta 
cell functional mass in the face of increasing insulin resistance (Meneilly and Elliot, 1999). 
Related to beta cell functions, aging correlates with a decrease of beta cell proliferation 
capacity and enhances sensitivity to apoptosis (Maedler et al., 2006). It has recently been 
proposed that an age-associated decline in mitochondrial function contributes to insulin 
resistance in the elderly (Petersen et al., 2003). Other metabolic diseases are also frequently 
related with aging such as coronary arterial disease, malignancies, cognitive disorders, and 
vitamin D deficiency (Yaffe et al., 200; Lu et al., 2009).  
2. Age and related risk factors for type 2 diabetes mellitus and 
cardiovascular diseases  
2.1. Age, mitochondrial dysfunction and inflammation 
Mitochondria, a membrane-enclosed organelle found in most eukaryotic cells, generate most 
of the cell's supply of adenosine triphosphate (ATP), are used as a source of chemical 
energy, and are involved in a range of other processes such as signaling, cellular 
differentiation, cell death, as well as the control of the cell cycle and cell growth. 
Mitochondria have been implicated in several human diseases, including mitochondrial 
disorders, aging process and cardiac dysfunction. Mitochondrial dysfunction is central to 
the theories of aging because age-related changes of mitochondria are likely to impair a host 
of cellular physiological functions in parallel and thus contribute to the development of all 
the common age-related diseases (Dai et al., 2012).  Rising cellular oxidative stress due to any 
cause induces mtDNA and mitochondria damage and culminates in a mitochondria 
function crisis, cell death and aging. Otherwise, aging itself causes abnormal mitochondrial 
morphology and cell death or apoptosis (Seo et al., 2010). Judge et al. (2005) in their study on 
rats found that accumulation of oxidant-induced damage in interfibrillar mitochondria 
might be a major contributing factor to the age-related alterations in myocardial function. 
How old age can be a major risk factor for CVD via mitochondrial dysfunction has been 
completely reviewed by Dai et al. (2012). 
Chronic inflammation is a characteristic feature of aging. A study by Sarkar et al. (2004) 
showed that human polynuleotide phosphrylase might play a significant role in producing 
pathological changes associated with aging by generating proinflammatory cytokines via 
reactive oxidative stress (reactive oxygen species(ROS) and NF-B. The role of NF-B in 
bridging the explanation of how aging is associated with inflammation and endothelial 
dysfunction is reviewed well by Csiszar et al. (2008). Another study has shown that 
depletion of cellular (GSH) during aging plays an important role in regulating the hepatic 
response to IL-1 (Rutkute et al., 2007). At rest, skeletal muscles of elderly people showed a 
lower number of macrophages, higher gene expression of several cytokines, and activation 
of stress signaling proteins, compared with skeletal muscles of young people (Peake et al., 
2010). Human aging is associated with the development of insulin resistance, -cell 
dysfunction and glucose intolerance.   The level of suppression of the TNF- production 
was observed and found to be significantly correlated with insulin action. Reduced 
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suppression of TNF- production in the elderly may in part contribute to the decline in 
insulin sensitivity (Kirwan et al., 2001). Hyperglycemia in patients with prediabetes and 
diabetes is associated with inflammation (de Rekeneire et al., 2006). 
2.2. Age and lipid metabolism 
Aging and age are often associated with lipid metabolism disorders. Lipid metabolism 
disorders that are associated with aging process constitute the early stage in the emergence 
of a constellation of risk factors for metabolic disorders (Sawabe et al., 2009; Gobal and 
Metha, 2010). After the age of 20 years, low-density lipoprotein cholesterol (LDL-C) 
increases significantly in both men and women. LDL-C does not increase or is in a flat state  
between the age of 50-60 years (male) and 60-70 years (female) (Gobal and Mehta, 2010). On 
the other hand, high–density lipoprotein cholesterol (HDL-C) levels decrease during 
puberty to young adulthood (in males). Throughout their lives women have lower total 
cholesterol compared to men, but the levels will rise sharply after menopause and will be 
higher in the age >60 years as compared to men. Concentrations of triglyceride (TG) increase 
sharply in males, reaching a peak at the age 40-50 years and decline gradually thereafter. TG 
levels increase in women throughout their lives, especially in women taking estrogen 
replacement therapy (Gobal and Mehta, 2010).  
With the increase of age the composition of body fat also increases, which especially 
accumulates in the abdomen triggering the incidence of central obesity. TG composition in 
the muscle and liver are higher in older age compared with younger age groups (Cree et al., 
2004). Increased body fat composition is associated with reduced fat oxidation both at rest 
and in activity (Nagy et al., 1996). Aging (age) affects the release of fatty acids (FFA),from fat 
tissue (adipose), and the capacity of peripheral tissues such as muscles, to oxidize fat. These 
are some of the changes in lipid metabolism influenced by age and aging, which decreases 
lipolysis response and capacity of fat oxidation. 
Lipolysis is modulated by various hormones such as catecholamines, glucagon, 
adrenocorticotropic hormone, growth hormone, prostaglandin, and thyroid hormone (Toth 
and Tchernof, 2000). Lipolysis response regulated by these hormones will decrease with 
aging. Decreased ability of catecholamines to stimulate lipolysis in the elderly is caused by 
decreased fat tissue response to adrenergic stimulation (Dillon et al., 1984). This response 
involves reduced role of protein kinase A, G-protein complex adenylil cyclase, or the stages in 
the cyclic AMP signaling cascade (Toth and Tchernof, 2000). Effects of insulin on plasma FFA 
was different between in the elderly compared with in younger subjects. Insulin infusions 
showed that plasma FFA, turnover and oxidation, and total lipid oxidation were higher 
significantly in the elderly than in the younger group (Bonadonna et al., 1994). Aging is also 
associated with decreased sensitivity to antilipolysis effects of insulin (Toth and Tchernof, 
2000). Hence this will also increase the release of free fatty acids to the blood in the elderly. 
Age is associated with decline in fat oxidation during activity, after meal and in resting 
condition (Robert et al., 1996). In principle, the capacity of metabolically active tissues such 
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as the muscles to oxidize fat represents a combination of the tissue mass and oxidative 
capacity of the tissue. Fat free mass decreases with age (Poehlman et al., 1992) and in resting 
condition fat oxidation tends to be influenced by the size of fat free mass itself. Changes in 
lipid metabolism in the aging process are associated with dysfunction of endothelial cells 
pseudocapillarization of the liver sinusoid. This change causes decreased endocytosis, 
increased leukocyte adhesion, decreased hepatic perfusion and will potentially reduce the 
passage of chylomicron remnants into hepatocytes (Denke and Grundy, 1990). After activity 
or after meal, fat oxidation rate is more influenced by the oxidative capacity of muscle 
tissue. Decreased muscle oxidative capacity with aging is associated with reduced activity of 
enzymes involved in oxidative metabolic processes (such as succinate dehydrogenase; 
citrate synthase; cytrochrome c oxidase) and β-oxidation of fatty acids (such as H-3-CoA 
dehydrogenase Hydroacyl) (Coggan et al., 1992; Rooyackers et al., 1996).   
Changes in lipid metabolism due to aging will lead to increased accumulation of body fat, 
resulting in increased concentrations of free fatty acids in the blood/plasma, and disposal of 
non-oxidative or free fatty acids. Increased concentrations of free fatty acids in blood 
increases glucose production, and this will inhibit insulin-stimulated glucose uptake and 
decrease hepatic insulin extraction (Fanelli et al., 1993; Toth and Tchernof, 2000). The 
changes will be followed by insulin resistance and hyperinsulinemia. Disposal of non-
oxidative free fatty acids into the liver will increase the formation of triglyceride-rich very 
low-density lipoprotein (VLDL) that plays a role in the formation of atherogenic 
dyslipidemia. Increased levels of TG and decrease HDL-C are features of atherogenic 
dyslipidemia  in people with central obesity, hypertension and insulin resistance (Linblad et 
al, 2001). In relation to BMI, although older age correlates with lower BMI and higher fat 
mass, dramatically decreased insulin sensitivity and lack of physical activity are the most 
important risk factors for metabolic disorders in the elderly (Gobal and Metha, 2010; Linbald 
et al., 2001). Insulin resistance itself is associated with decreased glucose carrier protein in 
the muscle (Sawabe et al., 2009). 
The incidence of heart attacks is higher in the elderly compared to middle age group with 
high cholesterol levels. Van der Meer et al. (2008) studied the association of myocardial TG 
content with diastolic function. They found that myocardial TG content was significantly 
associated with age (r = 0.57, p <0.05) and TG was negatively related to left ventricular 
diastolic function (r = 0.68, p <0.05). Multivariate analysis showed that myocardial TG 
content was an independent predictor (p <0.05) for decreased diastolic function associated 
with age. Lower HDL cholesterol is an important risk factor for not only ischemic heart 
disease but also for cerebrovascular disease, especially in diabetic elderly individuals 
(Hayashi et al., 2009).  
2.3. Age, insulin resistance and metabolic syndrome  
Metabolic syndrome is a group of  metabolic abnormalities of which central obesity and 
insulin resistance are believed  to be the primary backgrounds. The diagnostic criteria for 
metabolic syndrome have been proposed by several organizations  and associations, all of 
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which are based on five parameters i.e. central obesity, high blood pressure, high fasting 
blood glucose levels, high TG levels and low levels of HDL-C. The pathogenesis of how 
central obesity causes insulin resistance and metabolic syndrome has been explained in 
many publications. Decreased insulin sensitivity, reduced muscle mass, and increased body 
fat mass, especially visceral fat that accompanies aging contribute to insulin resistance in the 
elderly. Aging process is also associated with reduced compensatory beta cell mass function 
of the pancreas and to insulin resistance (Maneilly and Elliott, 1999) as well as with 
decreased mitochondrial function that contributes to insulin resistance (Petersen et al., 2003). 
A study by Gupta et al. (2000)  showed that hepatic insulin resistant was related to body fat 
and its distribution, and hepatic insulin action could be preserved by caloric restriction in 
aging caloric restriction rat. 
A study conducted in the metropolitan area of St. Louis on 100 women aged ≥ 65 years 
found higher fasting blood sugar levels in subjects with insulin resistance (94.1 ± 8.1 vs. 87.9 
± 8.2 mg/dl, p <0.05) (Banks et al., 2007). A study by Kuusisto et al. (2001) showed that the 
insulin resistance syndrome is a risk factor for coronary heart disease (CHD) in the elderly 
with a hazard ratio of 1.71. Insulin resistance as risk factor for cardiovascular disease (CVD) 
is associated with increase of acute phase protein response and inflammatory markers. The 
Rotterdam study that enrolled 574 non-diabetic elderly population showed that insulin 
correlated strongly and significantly with C-reactive protein (CRP), α-1-antichymotrypsin, 
interleukin (IL)-6 and soluble intercellular adhesion molecule-1, indicating that insulin 
resistance is an integral part of inflammation (Hak et al., 2001). A study by Suastika et al. 
(2011) on the population of Bali, Indonesia, has showed a tendency of increasing frequency 
of metabolic syndrome and its components with increasing age (Table 1). A study on the 
elderly by Zambon et al. (2009) found that metabolic syndrome was associated with increased 
mortality by various causes (HR 1:41) and mortality from CVD (HR 1.60). The association of 
metabolic syndrome and increased frequency of carotid plaque and thickening of the carotid 
artery intima media in elderly subjects (aged 65-85 years) was noted in a study by Empana et 
al. (2007). Subjects with metabolic syndrome have two-fold higher levels of oxidized LDL-C 
than those without Metabolic syndrome, and they are associated with increased risk of 
myocardial infarction with relative risk of 2.25 (Holvoet et al., 2004). Metabolic syndrome in the 
elderly was associated with two-times increase of CRP levels (3.1 vs. 1.5 mg/l), compared with 
the elderly without metabolic syndrome (Hassinen, 2006). 
Decreased physical activity/less exercise in the elderly has also contributed to the occurrence 
of obesity and metabolic syndrome. A study by Hahn et al. (2009) on subjects aged 55-74 
years found that regular exercise at least ≤1 hour per week reduced the risk of metabolic 
syndrome. Sports activities >2 hours per week would be effective in lowering the risk of 
metabolic syndrome.   
3. Age and type 2 diabetes mellitus  
Similar to metabolic syndrome, the prevalence of impaired fasting glycemia (IFG) and 
T2DM increase with rising age. In the United States, the estimated percentage of people 
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aged 20 years or older having diagnosed or undiagnosed diabetes in 2005-2008 was 
increasing with age. In the age group of 20-44 years, it was estimated about 3.7% people had 
diabetes; while in the age group 45-64 years the number increased to 13.7%; and the highest 
percentage of 26.9% was found in the age group of ≥ 65 years (Centers for Disease Control 
and Prevention, 2011). Similar feature was also observed n England, where the prevalence of 
diabetes was increasing with age. The peak prevalence of diabetes can be found in the age 
group of 65-74 years with 15.7% in men and 10.4% in women (Shelton, 2006). The study by 
Suastika et al. (2011) on Bali population showed that the prevalences of IFG and T2DM were 
higher in the elderly than in the younger age group, i.e. nearly two-fold and more than two 
fold, respectively (Figure 2). There was a tendency of increasing frequency of IFG and T2DM 
with increasing age (Table 2). Data from rural Taiwan showed that prevalence of DM was 
16.9% and that of IFG was 25.5% among elderly Chinese in 2000. During a 5 year follow up, 
cumulative prevalences of DM and IFG were 23.7% and 27.9%, respectively. The 5-years 
cumulative incidence of newly onset diabetes was 6.8%. Hypertension, overt proteinuria, 
IFG and high total cholesterol were independent risk factors for new onset diabetes (Peng et 
al., 2006).  
 
Metabolic syndrome and its 
components 
~19 
(%) 
20-29 
(%) 
30-39 
(%) 
40-49 
(%) 
50-59 
(%) 
60-69 
(%) 
≥70 
(%) 
Metabolic syndrome 
Increased waist circumference 
Elevated triglyceride 
Reduced HDL-cholesterol 
Elevated blood pressure 
Elevated fasting blood glucose 
5.5 
12.5 
1.7 
25.9 
12.5 
6.9 
4.8 
24.6 
10.3 
31.3 
15.1 
9.5 
15.9 
37.9 
24.6 
34.2 
19.2 
12.9 
17.6 
40.1 
26.1 
27.6 
31.5 
17.3 
29.6 
43.6 
31.3 
30.2 
45.8 
27.4 
26.0 
29.7 
25.9 
33.5 
55.1 
34.9 
17.3 
13.8 
18.3 
31.4 
60.0 
29.9 
Suastika et al. J Clin Gerontol Geriatrics 2011; 2: 47-52. 
Table 1. Frequency of metabolic syndrome and its components, by age (years) 
 
Figure 1. Frequency of metabolic syndrome (MS), impaired fasting glycemia (IFG), and diabetes 
mellitus (DM) in the younger-aged and elderly. Suastika et al. J Clin Gerontol Geriatrics 2011; 2: 47-52. 
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The prevalence of glucose intolerance (pre-diabetes and T2DM) increases with advancing 
age. Some factors involve in the pathophysiology of glucose intolerance in the elderly. The 
main factors are that aging induces decrease insulin sensitivity and alteration or insufficient 
compensation of beta cell functional in the face of increasing insulin resistance (Chang and 
Halter, 2003). Decrease in beta cell proliferation capacity and enhanced sensitivity to 
apoptosis are the states related with aging (Maedler et al., 2006).  A study by Szoke et al. 
(2008) showed that the first and second phase of insulin secretion normally decreases at the 
rate of approximately 0.7% per year with aging, this decrease in β cell function is accelerated 
about two-fold in people with impaired glucose tolerance. But aging per se has no effect on 
insulin sensitivity independent of change in body composition. Decline in lean body mass 
and the increase in body fat particularly visceral adipocytes (“central obesity”) that 
accompanies aging may contribute to insulin resistance. It has recently been proposed that 
an age-associated decline in mitochondrial function contributes to insulin resistance in 
elderly. Mitochondrial oxidative and phosphorylation function was reduced about 40% in 
association with increased intramyocellular and intrahepatocellular lipid content and 
decreased insulin-stimulated glucose uptake (Petersen et al., 2003). The pathophysiological 
basis of sarcopenia (loss of muscle mass with age) has a relationship with oxidative stress, 
reduced neuronal stimulation, subclinical inflammatory and insulin resistant state. Those 
conditions contribute to the development of glucose intolerance and type 2 diabetes 
(Khamseh et al., 2011).  
Minamino et al. (2009) in their study on mice proposed a model in which aging and 
inflammation was initiated in adipose tissue and subsequently induced insulin resistance in 
adipose tissue, liver and muscle. They also proposed that adipose tissue p53 tumor 
suppressor mediated the lipid abnormalities and cardiovascular morbidity associated with 
obesity. The study found that excessive calorie intake caused accumulation of oxidative 
stress in the adipose tissue of mice with type 2 diabetes–like disease and promoted 
senescence-like changes, such as increased activity of senescence-associated β-galactosidase, 
increased expression of p53 and increased production of proinflammatory cytokines. 
Inhibition of p53 activity in adipose tissue decreased the expression of proinflammatory 
cytokines and improved insulin resistance. Conversely, up-regulation of p53 in adipose 
tissue caused an inflammatory response that led to insulin resistance. 
 
Classification  ~19 
(N=59) 
20-29 
(N=201)
30-39 
(N=454)
40-49 
(N=490)
50-59 
(N=304)
60-69 
(N=199) 
≥70 
(N=111) 
Normoglycemia 
Impaired fasting glycemia 
Diabetes mellitus 
93.1 
6.9 
0 
90.5 
7.0 
2.5 
87.1 
10.9 
2.0 
82.7 
11.7 
5.6 
72.6 
16.9 
10.5 
65.1 
23.4 
11.5 
70.1 
17.8 
12.1 
Suastika et al. J Clin Gerontol Geriatrics 2011; 2: 47-52. 
Table 2. Frequency of glycaemic status (), by age (years) 
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4. Age and cardiovascular diseases  
Cardiovascular disease remains to be the most important cause of death in all countries over 
the world. Although certain reports from some developed countries indicate the incidence 
tends to decrease, from many countries there are reports mentioning that its incidence tends 
to increase. Cardiovascular disease is a complex disease; too many risk factors are involved 
in its pathogenesis. In general, risk factors for CVD can be divided into two main groups, 
namely traditional and non-traditional risk factors. Traditional risk factors include age 
(older than 40 years for men, 45 years for women), male sex, family history of coronary heart 
disease, smoking, hypertension, diabetes, central obesity, unhealthy cholesterol levels (high 
total cholesterol, low high-density lipoprotein [HDL] cholesterol, high low-density 
lipoprotein [LDL] cholesterol, high triglycerides), and low physical activity (Fonseca et al., 
2004; Torpy et al., 2009). In addition, some non-traditional risk factors for CVD are reported 
elsewhere (Fonseca et al., 2004; Vasan, 2006; Helfland et al., 2009).  
Several reviews have stressed that age is the strongest risk factor for CVD (Ref).  Age itself 
may be an independent risk factor or may have other risk factors related to aging or 
exposure to risk factors during their lifetime. In the United States, CVD was the leading 
cause of death for persons 65 years of age and over in 2007, which accounted for 28% of 
deaths in this age group (National Center for Health Statistics, 2011). In Asian population, 
age is also one of the most important determinants of CVD. The studies by Suastika et al. in 
a remote area of Ceningan Island found that coronary heart disease (CHD) prevalence was 
relatively high (11.5%), and older age (male ≥45 years and female ≥55 years) had higher risk 
for CHD than younger age group (OR, 27.0). By logistic regression analysis of all variables 
of the risk factors, age (β=3.937) consistently appeared to be the risk factor for CHD 
(Suastika et al., 2012a). Age in the group with CHD (old myocardial infarction and 
myocardial ischemia) was significantly higher than those without CHD (65.0 vs. 58.5 vs. 40.5 
years) (Suastika et al., 2012b). 
Several changes in cardiovascular system related with aging include changes in vascular 
function (increase wall thickening and arterial stiffening, endothelial dysfunction) and 
cardiac function (heart rate and cardiac output, left ventricular wall function and 
myocardial contraction). The stiffness of arterial walls  increase with age. This increase 
includes luminal enlargement with wall thickening and a reduction of elastic properties at 
the level of large elastic arteries. Long standing arterial pulsation in the central artery has a 
direct effect on the structural matrix proteins, collagen and elastin in the arterial wall, 
disrupting muscular attachments and causing elastin fibers to fatigue and fracture. 
Increased vascular calcification and endothelial dysfunction is also characteristic of arterial 
aging. These changes lead to increased pulse wave velocity, especially along central elastic 
arteries, and increase in systolic blood pressure and pulse pressure (Lee and Oh, 2010). 
Aging cardiovascular tissues are exemplified by pathological alterations including 
hypertrophy, altered left ventricular (LV) diastolic function, and diminished LV systolic 
reverse capacity, increased arterial stiffness, and impaired endothelial function. Study by 
Cheng et al. (2009) revealed that age was associated with a phenotype of LV remodeling 
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marked by increased mass-to-volume ratio and accompanied by systolic as well as diastolic 
myocardial dysfunction that is not reflected by preserved ejection fraction. This pattern of 
ventricular remodeling confers significant cardiovascular risk, particularly when present 
earlier in life.  
Peripheral artery disease (PAD), a marker of systemic atherosclerosis, is frequently related 
with age. It mostly starts at 40 and increases after the age 70 years. PAD is the independent 
risk factor for mortality caused by CVD (Norman et al., 2004). A study by Kuswardhani and 
Suastika (2010) on elderly patients who visited the Geriatric Outpatient Clinic, Sanglah 
Hospital showed that diabetic patients with PAD had higher age (70.7 vs. 65 years, p<0.001) 
and higher homocystein levels (13.4 vs. 11.5 mmol/L, p = 0.023), compared with those 
without PAD. High age (70-80 years) had 7.4 times risk than those with lower age (60-69 
years) and high homocystein levels (≥ 11 mmol/L) had 2.5 times risk than those with lower 
homocystein levels, to develop PAD. By multivariate analysis (logistic regression), it was 
found that only age played a role in PAD event.  
How the age/aging relates to T2DM and CVD based on above review is summarised in   
Figure 2. 
 
Figure 2. Summary of the relationship between  age/aging and type 2 diabetes mellitus and 
cardiovascular diseases. . 
5. Conclusion 
The number of elderly population has increased worldwide, and recently it has been 
increasing sharply in the developing countries. Prolong survival in the elderly  creates an 
impact on the appearance of metabolic diseases and CVD. Increase  in the prevalence of 
metabolic diseases (such as T2DM and CVD) in old age  may be related directly with age or 
aging process itself or indirectly through several other age-related risk factors of  T2DM and 
CVD such as central obesity, mitochondrial dysfunction, FFA and lipid metabolisms 
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disorders, inflammation, -cell dysfunction, insulin resistance, metabolic syndrome, and 
other factors which are not discussed in this review. 
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